Analysis

Justices To Clarify What's Fair Game With 'Skinny Labels'

By Ryan Davis · January 20, 2026, 9:13 PM EST

A new U.S. Supreme Court patent case that will require the justices to spell out what generic-drug makers can say when marketing drugs with so-called skinny labels will shape whether and...

To view the full article, register now.

Documents

Case Information

Case Title

Hikma Pharmaceuticals USA Inc., et al., Petitioners v. Amarin Pharma, Inc., et al.

Case Number

24-889

Court

Supreme Court

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

February 19, 2025